Latest News

Nvidia is going after a lucrative market that's currently dominated by AMD and Intel.

Enbridge stock currently has a strong dividend yield of almost 5%, with a business that's ready to meet the energy needs of the future.

This infrastructure builder just posted record numbers, yet the market is treating it like an afterthought.

Technically speaking, Bitcoin's floor is zero, but that's unlikely to happen if history is any guide.

Chemtrade’s monthly distribution has been climbing, and its cash-flow coverage suggests the payout isn’t just a headline.

One brand boasts a vast global reach, while the other delivers higher margins and faster growth. Explore how their fundamentals stack up for investors.

CareDx (NASDAQ:CDNA) executives outlined the company’s strategy to focus on precision diagnostics, expand into minimal residual disease testing and improve profitability during a Goldman Sachs-hosted discussion. Chief Executive Officer John Hanna said CareDx has reshaped its portfolio around areas

The protein comstibles maker is on the wrong side of a stock index rebalancing.

These TSX dividend stocks are supported by fundamentally strong businesses, resilient earnings, and sustainable payouts.

CIBC (TSX:CM) shares are still cheap and could be a great buy to pull ahead of inflation.

A strong quarter and its first stock split as a public company weren't enough to satisfy a stock priced for perfection.

These IPOs are bringing a lot of capital into the crypto sector via a brand new route that could have a beneficial spillover effect.

It's floating a large-scale convertible notes issue.

Buffett is known for his focus on stocks' valuations.

Is Byrna Technologies a hidden gem in the stock market or a risky bet? Join us as we evaluate its business potential, management, and financial health in this insightful episode of Scoreboard.

Bioventus (NASDAQ:BVS) executives outlined the company’s portfolio strategy, growth priorities and capital allocation plans during a Goldman Sachs event hosted by Jenny Rabinowitz, an analyst covering U.S. medtech and healthcare IT. Mark Singleton, Bioventus’ senior vice president and chief financi

Vail Resorts (NYSE:MTN) said historically poor weather across the Western United States continued to weigh on fiscal third-quarter results, pressuring visitation and revenue at its mountain resorts while management emphasized that its advance commitment pass model and cost controls helped cushion th

A maxed TFSA can become a tax-free income engine, and these three dividend payers offer different ways to get there.

The stock market is trading at historically expensive levels. That doesn't mean long-term investors should shy away from the S&P 500.

It blew past analyst estimates in its final quarter of fiscal 2026.

Visteon, a leader in automotive electronics, reported a notable insider sale amid strong share price gains over the past year.

Vail Resorts (MTN) Q3 2026 Earnings Transcript

These stocks may deliver gains during any market environment.